Biotech Values

[DewDiligence]

GTCB – What’s up with the albumin program?

>>
Re: hSA program:
by: DewDiligence
06/05/06 02:21 pm
Msg: 32779 of 32817

>Any updates on the HSA program (you have I believe quite correctly referred to this as GTCB's ace in the hole). This will be an amazing blockbuster once online.<

hSA is on the back burner for the time being while GTC presses forward with the phase-3 ATryn study in the U.S., which will be a demanding endeavor in terms of resource allocation.

I’m not sure I would describe hSA as a “blockbuster” because an excipient generates much less economic value per dosing unit than an active ingredient. Still, I think hSA has a lot of upside for GTC because albumin is an excellent protein stabilizer and the current sources of albumin—whether human or bovine—are risky.

[posted as a reply to: Msg 32689 by biopearl]
<<